mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |